View in EDS HTML Full Text PDF Full Text

Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.

Saved in:
Bibliographic Details
Title: Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
Authors: Schmitz A; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Brøndum RF; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Johnsen HE; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; For the Nordic Myeloma Study Group (NMSG)., Mellqvist UH; For the Nordic Myeloma Study Group (NMSG).; South Elvsborg Hospital, Boras, Sweden., Waage A; For the Nordic Myeloma Study Group (NMSG).; Norwegian University of Science and Technology and St. Olav's University Hospital, Trondheim, Norway., Gimsing P; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, University of Copenhagen, Copenhagen, Denmark., Op Bruinink DH; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van der Velden V; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van der Holt B; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; HOVON Data Center, Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hansson M; For the Nordic Myeloma Study Group (NMSG).; Skane University Hospital, Lund, Sweden., Andersen NF; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Frølund UC; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, Sjællands Universitetshospital, Roskilde, Denmark., Helleberg C; For the Nordic Myeloma Study Group (NMSG).; Department of Hematology, Herlev Hospital, Herlev, Denmark., Schjesvold FH; For the Nordic Myeloma Study Group (NMSG).; Oslo Myeloma Center, Department of Haematology, Oslo University Hospital, Olso, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway., Ahlberg L; For the Nordic Myeloma Study Group (NMSG).; Division of Hematology, Linkoping University Hospital, Linkoping, Sweden., Gulbrandsen N; For the Nordic Myeloma Study Group (NMSG).; Oslo Myeloma Center, Department of Haematology, Oslo University Hospital, Olso, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway., Andreasson B; For the Nordic Myeloma Study Group (NMSG).; NU Hospital Group, Uddevalla hospital, Uddevalla, Sweden., Lauri B; For the Nordic Myeloma Study Group (NMSG).; Sunderby Hospital, Luleaa, Sweden., Haukas E; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, Stavanger University Hospital, Stavanger, Norway., Bødker JS; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Roug AS; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Bøgsted M; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Severinsen MT; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Gregersen H; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; For the Nordic Myeloma Study Group (NMSG)., Abildgaard N; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, Odense University Hospital, Odense, Denmark., Sonneveld P; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; For the European Myeloma Network (EMN)., Dybkær K; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark. k.dybkaer@rn.dk.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark. k.dybkaer@rn.dk.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. k.dybkaer@rn.dk.
Source: BMC cancer [BMC Cancer] 2022 Feb 05; Vol. 22 (1), pp. 147. Date of Electronic Publication: 2022 Feb 05.
Publication Type: Evaluation Study; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35123422
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schmitz+A%22">Schmitz A</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Brøndum+RF%22">Brøndum RF</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Johnsen+HE%22">Johnsen HE</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; For the Nordic Myeloma Study Group (NMSG).<br /><searchLink fieldCode="AU" term="%22Mellqvist+UH%22">Mellqvist UH</searchLink>; For the Nordic Myeloma Study Group (NMSG).; South Elvsborg Hospital, Boras, Sweden.<br /><searchLink fieldCode="AU" term="%22Waage+A%22">Waage A</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Norwegian University of Science and Technology and St. Olav's University Hospital, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Gimsing+P%22">Gimsing P</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Op+Bruinink+DH%22">Op Bruinink DH</searchLink>; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Velden+V%22">van der Velden V</searchLink>; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Holt+B%22">van der Holt B</searchLink>; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; HOVON Data Center, Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hansson+M%22">Hansson M</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Skane University Hospital, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Andersen+NF%22">Andersen NF</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Frølund+UC%22">Frølund UC</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, Sjællands Universitetshospital, Roskilde, Denmark.<br /><searchLink fieldCode="AU" term="%22Helleberg+C%22">Helleberg C</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Department of Hematology, Herlev Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Schjesvold+FH%22">Schjesvold FH</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Oslo Myeloma Center, Department of Haematology, Oslo University Hospital, Olso, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Ahlberg+L%22">Ahlberg L</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Division of Hematology, Linkoping University Hospital, Linkoping, Sweden.<br /><searchLink fieldCode="AU" term="%22Gulbrandsen+N%22">Gulbrandsen N</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Oslo Myeloma Center, Department of Haematology, Oslo University Hospital, Olso, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Andreasson+B%22">Andreasson B</searchLink>; For the Nordic Myeloma Study Group (NMSG).; NU Hospital Group, Uddevalla hospital, Uddevalla, Sweden.<br /><searchLink fieldCode="AU" term="%22Lauri+B%22">Lauri B</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Sunderby Hospital, Luleaa, Sweden.<br /><searchLink fieldCode="AU" term="%22Haukas+E%22">Haukas E</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, Stavanger University Hospital, Stavanger, Norway.<br /><searchLink fieldCode="AU" term="%22Bødker+JS%22">Bødker JS</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Roug+AS%22">Roug AS</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Bøgsted+M%22">Bøgsted M</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Severinsen+MT%22">Severinsen MT</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Gregersen+H%22">Gregersen H</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; For the Nordic Myeloma Study Group (NMSG).<br /><searchLink fieldCode="AU" term="%22Abildgaard+N%22">Abildgaard N</searchLink>; For the Nordic Myeloma Study Group (NMSG).; Department of Haematology, Odense University Hospital, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Sonneveld+P%22">Sonneveld P</searchLink>; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; For the European Myeloma Network (EMN).<br /><searchLink fieldCode="AU" term="%22Dybkær+K%22">Dybkær K</searchLink>; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark. k.dybkaer@rn.dk.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark. k.dybkaer@rn.dk.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. k.dybkaer@rn.dk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2022 Feb 05; Vol. 22 (1), pp. 147. <i>Date of Electronic Publication: </i>2022 Feb 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Evaluation Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35123422
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-022-09184-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 147
    Titles:
      – TitleFull: Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schmitz A
      – PersonEntity:
          Name:
            NameFull: Brøndum RF
      – PersonEntity:
          Name:
            NameFull: Johnsen HE
      – PersonEntity:
          Name:
            NameFull: Mellqvist UH
      – PersonEntity:
          Name:
            NameFull: Waage A
      – PersonEntity:
          Name:
            NameFull: Gimsing P
      – PersonEntity:
          Name:
            NameFull: Op Bruinink DH
      – PersonEntity:
          Name:
            NameFull: van der Velden V
      – PersonEntity:
          Name:
            NameFull: van der Holt B
      – PersonEntity:
          Name:
            NameFull: Hansson M
      – PersonEntity:
          Name:
            NameFull: Andersen NF
      – PersonEntity:
          Name:
            NameFull: Frølund UC
      – PersonEntity:
          Name:
            NameFull: Helleberg C
      – PersonEntity:
          Name:
            NameFull: Schjesvold FH
      – PersonEntity:
          Name:
            NameFull: Ahlberg L
      – PersonEntity:
          Name:
            NameFull: Gulbrandsen N
      – PersonEntity:
          Name:
            NameFull: Andreasson B
      – PersonEntity:
          Name:
            NameFull: Lauri B
      – PersonEntity:
          Name:
            NameFull: Haukas E
      – PersonEntity:
          Name:
            NameFull: Bødker JS
      – PersonEntity:
          Name:
            NameFull: Roug AS
      – PersonEntity:
          Name:
            NameFull: Bøgsted M
      – PersonEntity:
          Name:
            NameFull: Severinsen MT
      – PersonEntity:
          Name:
            NameFull: Gregersen H
      – PersonEntity:
          Name:
            NameFull: Abildgaard N
      – PersonEntity:
          Name:
            NameFull: Sonneveld P
      – PersonEntity:
          Name:
            NameFull: Dybkær K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 02
              Text: 2022 Feb 05
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1